---
$id: https://graph.org.ai/products/commodity/51151648
$type: Product
source: UNSPSC
code: "51151648"
title: "Mebeverine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mebeverine

**UNSPSC Code**: 51151648
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticholinergic agent with the molecular formula C25H35NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7F80CC3NNV, chemically known as 4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl 3,4-dimethoxybenzoate but generally known as mebeverine, which bears US NIH Compound Identifier 4031. European Medicines Agency schedules Mebeverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08662MIG. The term MEBEVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 1, 1999, List 41). World Health Organization schedules mebeverine in its Anatomical Therapeutic Chemical (ATC) Classification. MEBEVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mebeverine under HS 29225000 and SITC 51467. As of Q4 2014, MEBEVERINE remains the US FDA Preferred Term for this commodity. Mebeverine bears US NLM identifiers UMLS ID C0065832 and NCI Concept Code C83909. SMILES: O(CCCCN(C(CC1CCC(OC)CC1)C)CC)C(=O)C1CC(OC)C(OC)CC1.

